WEB EXCLUSIVES
Active Pharmacovigilance and Healthcare Utilization
Jennifer S. Haas, MD, MSPH; Elissa Klinger, SM; Lucas Xavier Marinacci, BA; Phyllis Brawarsky, MPH; E. John Orav, PhD; Gordon D. Schiff, MD; and David W. Bates, MD, MSc
This study highlights the potential value of innovative ways of collecting information about adverse drug events directly from patients.
2012 Volume 18 Number 11
A Systematic Review of Reference Pricing: Implications for US Prescription Drug Spending
Joy Li-Yueh Lee, MS; Michael A. Fischer, MD, MS; William H. Shrank, MD, MSHS; Jennifer M. Polinski, ScD, MPH; and Niteesh K. Choudhry, MD, PhD
Reference pricing is an effective cost-containment tool widely used in other countries; it may be an attractive policy strategy for the US healthcare system.
2012 Volume 18 Number 11
Letter to the Editors: Response to Payer Coverage for Patients Enrolled Onto Clinical Trials
Yu-Ning Wong, MD, MSCE; Jeffery Ward, MD; and Michael Neuss, MD
2012 Volume 18 Number 11
Care Coordination Agreements: Barriers, Facilitators, and Lessons Learned
Emily Carrier, MD, MSc; Marisa K. Dowling, BA; and Hoangmai H. Pham, MD, MPH
Primary care providers have developed standing agreements with other healthcare providers and community-based organizations to coordinate care. Early experiences with these agreements are discussed.
2012 Volume 18 Number 11
How Comorbidities and Preoperative Expenditures Correlate With Postoperative Adverse Outcomes
Chih-Hsiung Wu, MD, PhD; Rei-Ming Chen, PhD; Hsiao-Chien Tsai, MD; Chuen-Chau Chang, MD, PhD; Hang Chang, MD, PhD; Chien-Chang Liao, PhD; and Ta-Liang Chen, MD, PhD
Adjusting for patients’ covariates, postoperative complications and mortality among geriatric surgical patients exhibited an age-dependent, illness-related, and preoperative medical expense–associated pattern under universal healthcare coverage.
2012 Volume 18 Number 11
Physician Factors That Influence Patient Referrals to End-of-Life Care
Alexis Coulourides Kogan, BS; Richard Brumley, MD; Kathleen Wilber, PhD; and Susan Enguidanos, PhD
This study used multivariate models to identify physician specialty and comfort with end-of-life discussions, both of which are associated with end-of-life referrals.
2012 Volume 18 Number 11
Identification of and Intervention to Address Therapeutic Gaps in Care
Daniel R. Touchette, PharmD, MA; Sapna Rao, BPharm, MS; Purna K. Dhru, PharmD; Weihan Zhao, PhD; Young-Ku Choi, PhD; Inderpal Bhandari, PhD; and Glen D. Stettin, MD
A program identifying and resolving care gaps involving community pharmacists resulted in increased adherence and omission gaps closure and fewer adherence gap reopenings.
2012 Volume 18 Number 10
EMR-Based Medication Adherence Metric Markedly Enhances Identification of Nonadherent Patients
Shepherd Roee Singer, MD, MPH; Moshe Hoshen, PhD; Efrat Shadmi, PhD; Morton Leibowitz, MD; Natalie Flaks-Manov, MPH; Haim Bitterman, MD; and Ran D. Balicer, MD, PhD
Integration of written-prescription data into medication adherence measures doubled the number of patients identified as nonadherent and improved prediction of follow-up LDL cholesterol.
2012 Volume 18 Number 10
Financial Incentives and Physician Commitment to Guideline-Recommended Hypertension Management
Sylvia J. Hysong, PhD; Kate Simpson, MPH; Kenneth Pietz, PhD; Richard SoRelle, BS; Kristen Broussard Smitham, MBA, MA; and Laura A. Petersen, MD, MPH
Financial incentives may not be strong enough to influence physician goal commitment to guideline-recommended hypertension care when providers attribute performance to forces beyond their control.
2012 Volume 18 Number 10
Identifying Frail Older People Using Predictive Modeling
Shelley A. Sternberg, MD; Netta Bentur, PhD; Chad Abrams, MA; Tal Spalter, MA; Tomas Karpati, MD; John Lemberger, MA; and Anthony D. Heymann, MB BS
The frailty determination of the Adjusted Clinical Groups–diagnoses based predictive model identified frail elders with moderate success compared with a validated screening questionnaire.
2012 Volume 18 Number 10